Biotech companies' fundraising woes means "we will see more biotech companies looking for an acquisition, " says Daniel L. Zabrowski, Roche's global head of drug deals.

FORBES: Magazine Article

Novartis (nyse: NVS - news - people ) Chief Executive Daniel Vasella says he's not interested in making a bid for Roche right away.

FORBES: Magazine Article

Novartis (nyse: NVS - news - people ) Chief Executive Daniel Vasella seems intent on taking over his Basel, Switzerland-based neighbor Roche someday.

FORBES: Magazine Article